Cargando…
Tuberculosis and TNF-α inhibitors in children: how to manage a fine balance
Since the introduction of biologic response modifiers (BRMs) in the management of children affected by the immune-mediated inflammatory disease, these patients substantially improved their quality of life. BRMs are generally well tolerated and effective in most children and adolescents refractory to...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mattioli 1885
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023060/ https://www.ncbi.nlm.nih.gov/pubmed/33004779 http://dx.doi.org/10.23750/abm.v91i11-S.10311 |